{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:30Z","timestamp":1787026530392,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["280873 - ADITEC"],"award-info":[{"award-number":["280873 - ADITEC"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung f\u00fcr Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02118","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T06:47:59Z","timestamp":1537339679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12\/HMGB1 in Active Rheumatoid Arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Valentina","family":"Cecchinato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Raeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Nerviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Schiraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Danelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco E.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rubartelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Uguccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","article-title":"Interleukin-1 function and role in rheumatic disease","volume":"12","author":"Schett","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis - shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrrheum.2015.161","article-title":"Targeting GM-CSF in inflammatory diseases","volume":"12","author":"Wicks","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI117060","article-title":"Cyclooxygenase-1 and\u22122 expression in rheumatoid synovial tissues","volume":"93","author":"Crofford","year":"1994","journal-title":"J Clin Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Pharmacology","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/ard.2005.037176","article-title":"Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis","volume":"65","author":"Haringman","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/art.23667","article-title":"Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor","volume":"58","author":"Rioja","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1002\/art.22964","article-title":"Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker","volume":"56","author":"Wijbrandts","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.10102","article-title":"Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice","volume":"46","author":"Blades","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/eji.200425830","article-title":"Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis","volume":"35","author":"Manzo","year":"2005","journal-title":"Eur J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2005.11.001","article-title":"Chemokine blockers\u2013therapeutics in the making?","volume":"27","author":"Wells","year":"2006","journal-title":"Trends Pharmacol Sci."},{"key":"B13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1084\/jem.186.1.131","article-title":"An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model","volume":"186","author":"Gong","year":"1997","journal-title":"J Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejphar.2014.06.060","article-title":"Chemokine receptors as therapeutic targets: Why aren't there more drugs?","volume":"746","author":"Solari","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.it.2007.08.004","article-title":"Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox","volume":"28","author":"Rubartelli","year":"2007","journal-title":"Trends Immunol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1432-1033.1973.tb03026.x","article-title":"A new group of chromatin-associated proteins with a high content of acidic and basic amino acids","volume":"38","author":"Goodwin","year":"1973","journal-title":"Eur J Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1089\/ars.2010.3356","article-title":"High-mobility group box 1, oxidative stress, and disease","volume":"14","author":"Tang","year":"2011","journal-title":"Antioxid Redox Signal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","article-title":"HMGB1 and leukocyte migration during trauma and sterile inflammation","volume":"55","author":"Venereau","year":"2013","journal-title":"Mol Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Tang","year":"2010","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J Exp Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12601","article-title":"High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair","volume":"280","author":"Bianchi","year":"2017","journal-title":"Immunol Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20160217","article-title":"High mobility group box 1 orchestrates tissue regeneration via CXCR4","volume":"215","author":"Tirone","year":"2018","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E4463","DOI":"10.1073\/pnas.1802893115","article-title":"Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert","volume":"115","author":"Lee","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","first-page":"46","article-title":"The Role of chemokine receptor CXCR4 in breast cancer metastasis","volume":"3","author":"Mukherjee","year":"2013","journal-title":"Am J Cancer Res."},{"key":"B26","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.163.6.3037","article-title":"Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex","volume":"163","author":"Vila-Coro","year":"1999","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/eji.200323897","article-title":"Chemokines integrate JAK\/STAT and G-protein pathways during chemotaxis and calcium flux responses","volume":"33","author":"Soriano","year":"2003","journal-title":"Eur J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2165\/11208240-000000000-00000","article-title":"Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis","volume":"71","author":"McCormack","year":"2011","journal-title":"Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6","article-title":"Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis","volume":"42","author":"Maurice","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2543","DOI":"10.1097\/MD.0000000000002543","article-title":"Plasma and synovial fluid TrxR levels are correlated with disease risk and severity in patients with rheumatoid arthritis","volume":"95","author":"Xie","year":"2016","journal-title":"Medicine"},{"key":"B33","doi-asserted-by":"crossref","first-page":"24161","DOI":"10.1016\/S0021-9258(18)35742-9","article-title":"Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway","volume":"267","author":"Rubartelli","year":"1992","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1073\/pnas.022630299","article-title":"Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation","volume":"99","author":"Angelini","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1038\/sj.emboj.7601746","article-title":"Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1","volume":"26","author":"Schwertassek","year":"2007","journal-title":"EMBO J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/annrheumdis-2016-209201","article-title":"Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions","volume":"75","author":"Schett","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","article-title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","volume":"64","author":"Anderson","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0076-6879(97)87018-8","article-title":"Chemical synthesis, purification, and folding of C-X-C and C-C chemokines","volume":"287","author":"Clark-Lewis","year":"1997","journal-title":"Methods Enzymol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1021\/bi049364k","article-title":"The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes","volume":"43","author":"Knapp","year":"2004","journal-title":"Biochemistry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.1830250113","article-title":"Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1\u03b1 and MIP-1\u03b2 on human monocytes","volume":"25","author":"Uguccioni","year":"1995","journal-title":"Eur J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2353\/ajpath.2007.061275","article-title":"CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis","volume":"171","author":"Manzo","year":"2007","journal-title":"Am J Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0161-5890(01)00113-4","article-title":"Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis","volume":"38","author":"Jikimoto","year":"2002","journal-title":"Mol Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1073\/pnas.1000779107","article-title":"Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion","volume":"107","author":"Tassi","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B47","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"Von","year":"2005","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1182\/blood-2004-04-1648","article-title":"A rich chemokine environment strongly enhances leukocyte migration and activities","volume":"105","author":"Paoletti","year":"2005","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/eji.200525800","article-title":"CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine","volume":"35","author":"Sebastiani","year":"2005","journal-title":"Eur J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jphs.09R03CP","article-title":"Prostaglandin E2, an immunoactivator","volume":"112","author":"Sakata","year":"2010","journal-title":"J Pharmacol Sci."},{"key":"B52","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","article-title":"The chemokine SDF-1\u03b1 The chemokine SDF-1n immunoactivator","volume":"13","author":"Vila-Coro","year":"1999","journal-title":"FASEB J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13075-017-1278-0","article-title":"Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis","volume":"19","author":"Kuuliala","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"14737","DOI":"10.1073\/pnas.2434516100","article-title":"Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics","volume":"100","author":"Laragione","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1189\/jlb.1MR1015-457R","article-title":"Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking","volume":"99","author":"Cecchinato","year":"2016","journal-title":"J Leukoc Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2016.00183","article-title":"Modulation of chemokine responses: synergy and cooperativity","volume":"7","author":"Proudfoot","year":"2016","journal-title":"Front Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/BOR.0000000000000529","article-title":"Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics","volume":"30","author":"Bridgewood","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1189\/jlb.0908576","article-title":"Requirement of HMGB1 for stromal cell-derived factor-1\/CXCL12-dependent migration of macrophages and dendritic cells","volume":"86","author":"Campana","year":"2009","journal-title":"J Leukoc Biol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T02:46:35Z","timestamp":1693881995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2018.02118"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02118","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"article-number":"2118"}}